BCHTD SEC Filings

Birchtech Corp. reported stronger first-quarter activity but remains loss-making. Revenue rose to $4.24 million from $3.22 million, driven by higher product sales, while license revenue dropped to zero. Gross profit was $1.38 million, and the company recorded a net loss of $1.35 million, or $0.06 per share, compared with a $1.68 million loss a year earlier.

Liquidity improved significantly after a February–March underwritten stock offering of 6.85 million shares that generated gross proceeds of $16.44 million. Cash increased to $14.75 million at March 31, 2026, up from $2.25 million at year-end, and stockholders’ equity turned positive at $11.17 million. Management now believes existing cash and expected revenue can fund operations for at least 12 months.

The balance sheet includes a related-party profit share liability of $7.09 million, tied to future net litigation proceeds from enforcing Birchtech’s mercury-control patents. A final judgment of $78.40 million (including pre-judgment interest) was entered in December 2025 against certain CERT defendants, but it has not been recognized as an asset because collection remains uncertain and the defendants have appealed. Birchtech is also advancing water-treatment technologies for PFAS and PFOS, supported by new design centers in Pennsylvania and North Dakota.

Birchtech Corp. filed an initial Form 3 insider report for Mioska Michael David, who serves as Chief Financial Officer. The filing, as provided, does not list any equity holdings or report any buy, sell, or other insider transactions for him.

Birchtech Corp. filed an initial Form 3 insider report for Mioska Michael David, who serves as Chief Financial Officer. The filing, as provided, does not list any equity holdings or report any buy, sell, or other insider transactions for him.

Birchtech Corp. has appointed experienced finance executive Michael Mioska, CPA, MBA, as Chief Financial Officer. He has over 20 years of accounting, audit and financial reporting experience across the United States and Canada and has consulted for Birchtech since 2023.

Mioska has worked closely with Birchtech’s finance team, giving him deep familiarity with the company’s operations, systems and strategic priorities. Management expects his capital markets, M&A and reporting expertise to support the next phase of growth in Birchtech’s specialty activated carbon air and water treatment businesses.

Birchtech Corp. has appointed experienced finance executive Michael Mioska, CPA, MBA, as Chief Financial Officer. He has over 20 years of accounting, audit and financial reporting experience across the United States and Canada and has consulted for Birchtech since 2023.

Mioska has worked closely with Birchtech’s finance team, giving him deep familiarity with the company’s operations, systems and strategic priorities. Management expects his capital markets, M&A and reporting expertise to support the next phase of growth in Birchtech’s specialty activated carbon air and water treatment businesses.

Birchtech Corp. set the date for its 2026 Annual Meeting of Stockholders for Thursday, July 23, 2026, to be held as a virtual-only meeting conducted via remote communications. The company will provide the exact time, access details, and agenda items in its upcoming proxy statement.

Because no annual meeting was held in 2025, stockholders seeking to include proposals in the 2026 proxy materials under Rule 14a-8 must deliver them to the company’s Corsicana, Texas headquarters by the close of business on May 26, 2026. The same deadline applies to stockholder proposals or director nominations submitted outside Rule 14a-8, all of which must satisfy the advance notice provisions in Birchtech’s amended and restated bylaws.

Birchtech Corp. set the date for its 2026 Annual Meeting of Stockholders for Thursday, July 23, 2026, to be held as a virtual-only meeting conducted via remote communications. The company will provide the exact time, access details, and agenda items in its upcoming proxy statement.

Because no annual meeting was held in 2025, stockholders seeking to include proposals in the 2026 proxy materials under Rule 14a-8 must deliver them to the company’s Corsicana, Texas headquarters by the close of business on May 26, 2026. The same deadline applies to stockholder proposals or director nominations submitted outside Rule 14a-8, all of which must satisfy the advance notice provisions in Birchtech’s amended and restated bylaws.

Birchtech Corp. expanded its recent stock sale through a partial use of the underwriters’ over-allotment option. The company originally sold 6,250,000 common shares at $2.40 per share, generating gross proceeds of $15.0 million.

On March 17, 2026, the underwriters bought an additional 600,000 shares at the same price, adding approximately $1.4 million of gross proceeds. In total, 6,850,000 shares have been issued in the offering, with aggregate gross proceeds of about $16.4 million and 337,500 over-allotment shares still available.

Birchtech Corp. expanded its recent stock sale through a partial use of the underwriters’ over-allotment option. The company originally sold 6,250,000 common shares at $2.40 per share, generating gross proceeds of $15.0 million.

On March 17, 2026, the underwriters bought an additional 600,000 shares at the same price, adding approximately $1.4 million of gross proceeds. In total, 6,850,000 shares have been issued in the offering, with aggregate gross proceeds of about $16.4 million and 337,500 over-allotment shares still available.

Birchtech Corp. completed an underwritten public offering of 6,250,000 shares of common stock at $2.40 per share, generating approximately $13.1 million in net proceeds. Underwriters also have a 30‑day option to buy up to 937,500 additional shares, which would lift net proceeds to about $15.2 million if fully exercised.

The company plans to use the cash, together with existing funds, for ongoing operating expenses, working capital and other general corporate purposes. Birchtech’s CEO purchased $750,000 of stock in the deal, or 312,500 shares, and directors and executive officers agreed to a 90‑day lock‑up. The offering supports Birchtech’s uplisting, as its common stock was approved for trading on the NYSE American under the symbol BCHT while remaining listed on the Toronto Stock Exchange.

Birchtech Corp. completed an underwritten public offering of 6,250,000 shares of common stock at $2.40 per share, generating approximately $13.1 million in net proceeds. Underwriters also have a 30‑day option to buy up to 937,500 additional shares, which would lift net proceeds to about $15.2 million if fully exercised.

The company plans to use the cash, together with existing funds, for ongoing operating expenses, working capital and other general corporate purposes. Birchtech’s CEO purchased $750,000 of stock in the deal, or 312,500 shares, and directors and executive officers agreed to a 90‑day lock‑up. The offering supports Birchtech’s uplisting, as its common stock was approved for trading on the NYSE American under the symbol BCHT while remaining listed on the Toronto Stock Exchange.

Birchtech Corp. plans a primary offering of 4,464,286 shares of common stock, with an assumed price of $3.36 per share, and has granted underwriters a 30‑day option for 669,643 additional shares. Estimated net proceeds are about $13.1 million, or $15.2 million if the option is fully exercised.

The company provides specialty activated carbon technologies for mercury emissions control at coal‑fired power plants and is expanding into PFAS-focused water treatment. As of February 11, 2026, 19,455,966 shares were outstanding, rising to 23,920,252 after the offering. Key risks include heavy reliance on evolving U.S. environmental regulations, customer concentration, active patent challenges, going‑concern uncertainty, and dependence on collection of a $78.4 million patent judgment that is under appeal.

Birchtech Corp. plans a primary offering of 4,464,286 shares of common stock, with an assumed price of $3.36 per share, and has granted underwriters a 30‑day option for 669,643 additional shares. Estimated net proceeds are about $13.1 million, or $15.2 million if the option is fully exercised.

The company provides specialty activated carbon technologies for mercury emissions control at coal‑fired power plants and is expanding into PFAS-focused water treatment. As of February 11, 2026, 19,455,966 shares were outstanding, rising to 23,920,252 after the offering. Key risks include heavy reliance on evolving U.S. environmental regulations, customer concentration, active patent challenges, going‑concern uncertainty, and dependence on collection of a $78.4 million patent judgment that is under appeal.

Birchtech Corp. is conducting a primary offering of 5,449,592 shares of common stock, based on an assumed public offering price of $3.67 per share. The company expects to raise approximately $17.7 million in net proceeds, or about $20.5 million if underwriters fully exercise a 817,439‑share over‑allotment option.

Shares outstanding are expected to increase from 19,455,966 to 24,905,558. Birchtech plans to use the cash, together with existing funds, for ongoing operating expenses, working capital, and general corporate purposes. The company has applied to list its stock on the NYSE American under the symbol “BCHT”, with NYSE American approval a condition to closing the deal; trading would cease on the OTCQB if the uplisting occurs.

Birchtech provides specialty activated carbon technologies for mercury emissions control at coal‑fired power plants and is expanding into water treatment focused on PFAS removal. It highlights regulatory uncertainty around U.S. emissions and water rules, customer concentration, patent protection challenges, and a going concern risk given a year‑end 2025 cash balance of about $2.3 million.

Birchtech Corp. is conducting a primary offering of 5,449,592 shares of common stock, based on an assumed public offering price of $3.67 per share. The company expects to raise approximately $17.7 million in net proceeds, or about $20.5 million if underwriters fully exercise a 817,439‑share over‑allotment option.

Shares outstanding are expected to increase from 19,455,966 to 24,905,558. Birchtech plans to use the cash, together with existing funds, for ongoing operating expenses, working capital, and general corporate purposes. The company has applied to list its stock on the NYSE American under the symbol “BCHT”, with NYSE American approval a condition to closing the deal; trading would cease on the OTCQB if the uplisting occurs.

Birchtech provides specialty activated carbon technologies for mercury emissions control at coal‑fired power plants and is expanding into water treatment focused on PFAS removal. It highlights regulatory uncertainty around U.S. emissions and water rules, customer concentration, patent protection challenges, and a going concern risk given a year‑end 2025 cash balance of about $2.3 million.